Dave Fornell, DAIC Editor

Dave Fornell, Editor DAIC

Blog | Dave Fornell, DAIC Editor | May 24, 2012

Insights on Electrophysiology from Heart Rhythm 2012


Most advances in medicine are small and incremental, but once in a while there is a rapid leap forward that draws excitement and  provides a breath of spring air in an otherwise stagnant environment. This was the feeling at the Heart Rhythm Society (HRS) 2012 scientific sessions in Boston last week in response to two new technologies that may change the way electrophysiology is practiced. The first is Cameron Health’s subcutaneous implantable cardioverter defibrillator (S-ICD) pending final U.S. Food and Drug Administration (FDA) review. The second is a new technique called FIRM, used to clearly visualize electrical activity around rotor cores in atrial fibrillation patients to precisely guide ablations. In some cases, FIRM shortened the usual four- to six-hour ablation procedure time to just minutes.

Device-wise, the S-ICD system was a favorite and the Cameron booth was packed during much of the show. The system uses leads that are placed just under the skin under direct visualization, so there is no need for angiography and it eliminates the need for venous access, endovenous leads and cardiac lead fixation. The system was also designed to be extremely simple to use and program. Boston Scientific is working on a deal to purchase the company. If approved by the FDA later this summer, the S-ICD will be the first implantable EP device to use a subcutaneous lead system, likely the first of many devices to come. Click here to see a video or click here to read more about European trial results.

Procedurally, the FIRM technology discussed in a new EP technology session was a big topic of discussion. It offers a new way to visualize electrical activity in atrial fibrillation to more effectively and quickly ablate and terminate the arrhythmia. For more information, click here to read the story.

Perhaps because of growing interest in expanding or creating new EP programs, the HRS exhibit floor was noticeably packed with attendees, more so than other cardiology shows I’ve attended over the past couple of years.

A new study on the high malfunction rate of the Riata lead was presented at HRS, adding further concern about the lead. To watch the press conference video, click here.

I also created a video touching on some of the top trends and new technology highlighted on the expo floor of HRS. To watch the video, click here.

Finally, as healthcare marches toward total integration of all reports, imaging and waveforms into the electronic medical report, there has been increased interest in electrophysiology reporting modules. DAIC spoke to EP and IT expert Michael Mirro, M.D., who explained what hospitals should look for in these systems. To watch the video of this interview, click here.


Related Content

iRhythm Technologies, ZIO continuous cardiac monitoring service, myZIO app, irregular heartbeat symptoms, reporting

Image courtesy of iRhythm Technologies

Technology | ECG Monitoring Services| November 19, 2015
iRhythm Technologies Inc. announced the launch of new patient engagement tools to enhance the diagnosis of cardiac...
wearable Holter monitors, iRhythm, ziopatch, zio patch

iRhythm Technologies Zio Patch was among the first of a new generation of simplified, wearable Holter monitors designed to increase ease of use and patient compliance to increase detection of arrhythmias that may lead to stroke.

Feature | Holter Monitoring Systems| November 16, 2015 | Judy Lenane, RN, MHA
One-third of ischemic strokes are classified as cryptogenic.
Medtronic, Micra TPS, Global Clinical Trial, results

Image courtesy of Medtronic

News | Pacemakers| November 11, 2015
 Medtronic plc announced that the Medtronic Micra Transcatheter Pacing System (TPS) was successfully implanted in...
LivaNova, Platinum, ICD, CRT-D, launch, Europe and Japan

Image courtesy of LivaNova PLC

News | Implantable Cardioverter Defibrillators (ICD)| November 04, 2015
LivaNova PLC, formerly Sorin Group, launched Platinum, a new range of implantable cardiac defibrillators (ICDs) and...
StopAfib.org, atrial fibrillation, AF-related stroke, patient engagement materials

Infographic courtesy of StopAfib.org

News | Stroke| November 03, 2015
In recognition of World Stroke Day, the patient-focused organization StopAfib.org launched a diverse set of materials...
News | Heart Failure| November 02, 2015
Medical device developer Cardionomic Inc. announced that it has received $20 million in Series A financing. Investors...
Boston Scientific, CE Mark, MRI conditional labeling, CRT-Ds, ICDs

X4 CRT-D system image courtesy of Boston Scientific

News | EP Lab| October 30, 2015
Boston Scientific Corp. has received CE Mark on magnetic resonance imaging (MRI) conditional labeling for the current...
Stereotaxis, Niobe remote magnetic navigation system, respiratory compensation, cardiac ablation
Technology | Robotic Systems| October 28, 2015
Stereotaxis Inc. announced the worldwide launch of Respiratory Compensation, a new software feature of the company’s...
Praxbind, Pradaxa reversal agent, FDA approval, emergency situations
Technology | Antiplatelet and Anticoagulation Therapies| October 19, 2015
The U.S. Food and Drug Administration (FDA) granted accelerated approval to Praxbind (idarucizumab) for use in patients...
AtriCure, definitive merger agreement, nContact Inc., atrial fibrillation solutions, cardiac ablation
News | Ablation Systems| October 14, 2015
AtriCure Inc. announced it has entered into a definitive merger agreement under which AtriCure has agreed to acquire...
Overlay Init